[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352309-105":59,"doc-detail-352309-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","impact-of-immunotherapy-and-small-molecule-cancer-therapy-on-fertility-a-narrative-review-of-current-evidence-mechanisms-and-future-directions","Impact of immunotherapy and small molecule cancer therapy on fertility - a narrative review of current evidence, mechanisms and future directions","","With increasing cancer incidence among individuals of reproductive age, preserving fertility has become a critical aspect of cancer care. This narrative review examines how contemporary therapies, including immunotherapies and targeted agents, affect reproductive health, summarizing clinical fertility outcomes and biological mechanisms. It reviews reproductive physiology, outlines epidemiology and treatment strategies for adolescent and young adult malignancies, and discusses proposed gonadotoxic mechanisms and limits of current evidence. It emphasizes precautionary fertility preservation, multidisciplinary care, and future research needs.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-immunotherapy-and-small-molecule-cancer-therapy-on-fertility-a-narrative-review-of-current-evidence-mechanisms-and-future-directions/352309/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-immunotherapy-and-small-molecule-cancer-therapy-on-fertility-a-narrative-review-of-current-evidence-mechanisms-and-future-directions/352309.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is fertility preservation considered critical for cancer patients of reproductive age?","Question",{"text":113,"@type":114},"Cancer incidence among individuals of reproductive age is increasing, and preserving fertility becomes a key part of cancer care and survivorship planning. The review also links fertility concerns to long-term psychological distress and the need for informed decision-making.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cancer therapies are highlighted as potentially affecting fertility?",{"text":118,"@type":114},"The review focuses on immunotherapies such as checkpoint inhibitors, cell-based therapies (including CAR T cells and tumor-infiltrating lymphocytes), and monoclonal antibodies. It also covers small-molecule targeted therapies, including kinase inhibitors (e.g., BRAF, MEK, EGFR) and agents such as PARP inhibitors and apoptosis promoters like BCL-2 inhibitors.",{"name":120,"@type":111,"acceptedAnswer":121},"What are the main limitations of current evidence on reproductive safety?",{"text":122,"@type":114},"Available evidence is limited, heterogeneous, and often lacks baseline fertility assessment or long-term follow-up. This uncertainty complicates counselling, supporting a precautionary approach to fertility preservation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352309,1790547102,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Open access Review  \nImpact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions  \nEmma Gargus,1 Sohei Kuribayashi,2 Scott D Lundy,2 Seth Rotz,3 Laila Alkhouli,3 Parker L Bussies,1 Tommaso Falcone  1  \nTo cite: Gargus E, Kuribayashi S, Lundy SD, et al. Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions. BMJ Oncology 2026;5:e000843 . doi:10 . 1136/ bmjonc-2025-000843  \nReceived 07 October 2025 Accepted 08 January 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Obstetrics & Gynecology, Cleveland Clinic, Cleveland, Ohio, USA  \n2Urology, Cleveland Clinic, Cleveland, Ohio, USA 3Pediatric Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA  \nCorrespondence to  \nDr Tommaso Falcone; [FALCONT@ccf.org](FALCONT@ccf.org)  \nABSTRACT  \nWith increasing cancer incidence among individuals of reproductive age, preserving fertility has become a critical aspect of cancer care. This narrative review explores the impact of contemporary cancer therapies, including immunotherapies and targeted agents, on reproductive health, highlighting clinical fertility outcomes and underlying biological mechanisms. We outline the epidemiology and treatment strategies for malignancies common in adolescents and young adults (AYAs), including breast, melanoma, lung, gynaecologic, colorectal cancers and haematologic malignancies.  \nBasic reproductive physiology in males and females is reviewed, including the hypothalamic–pituitary–gonadal axis, ovarian follicle and oocyte development, and spermatogenesis. Clinical data related to fertility and reproductive outcomes in patients receiving immunotherapy or targeted therapy are summarised, along with proposed mechanisms of gonadotoxicity from both conventional chemotherapy and newer drug classes. Special emphasis is placed on immunotherapy, such as checkpoint inhibitors, cell-based therapies (eg, chimeric antigen receptor T cells, tumour-infiltrating lymphocytes) and monoclonal antibodies, and smallmolecule inhibitors, including kinase inhibitors (eg, BRAF, MEK, epidermal growth factor receptor), poly (ADP-ribose) polymerase inhibitors, epigenetic modifiers and apoptosis promoters (eg, BCL-2 inhibitors) . Despite their growing use, these therapies are poorly studied in terms of reproductive safety, with available evidence being limited, heterogeneous and often lacking baseline fertility assessments or long-term follow-up. This uncertainty complicates counselling and decisionmaking, requiring a precautionary approach to fertility preservation. Multidisciplinary collaboration incorporating oncology, reproductive medicine, psychology and ethics is essential for individualised, ethically sound care. Emerging technologies such as organ-on-chip systems and induced pluripotent stem cell models offer promising avenues for mechanistic insight. To advance the field, future efforts must focus on prospective cohort studies, robust preclinical models and interim clinical guidelines to support informed fertility-related care for cancer patients.  \nINTRODUCTION  \nEpidemiology of malignancies in reproductive age people  \nThe US National Cancer Institute defines adolescents and young adults (AYAs) with cancer as individuals aged 15–39 years.1 AYAs comprise approximately 5% of cancer diagnoses worldwide,2 with approximately 70 000 new cancer diagnoses annually in the US.3 Malignancies among AYAs may differ from other age groups due to differences in cancer type distribution, environmental risk factors, tumour and host biology, response to treatment and stage at presentation.4 5  \nCancer incidence among AYAs has been rising.6 Malignancy types among AYAs vary by age subgroup (table 1) . Adolescents aged 15–19 years most frequently develop lymphomas,","cbCaio8W0jLrxzjL","https://ap.wps.com/l/cbCaio8W0jLrxzjL","pdf",813833,17,"English","# Abstract\n# Introduction\n## Epidemiology of malignancies in reproductive age people\n## Importance of fertility preservation in AYAs\n# Reproductive physiology and mechanisms of gonadotoxicity\n## Male and female reproductive physiology\n## Proposed mechanisms of therapy-related gonadotoxicity\n# Clinical evidence for fertility outcomes\n# Future directions","[{\"question\":\"Why is fertility preservation considered critical for cancer patients of reproductive age?\",\"answer\":\"Cancer incidence among individuals of reproductive age is increasing, and preserving fertility becomes a key part of cancer care and survivorship planning. The review also links fertility concerns to long-term psychological distress and the need for informed decision-making.\"},{\"question\":\"Which cancer therapies are highlighted as potentially affecting fertility?\",\"answer\":\"The review focuses on immunotherapies such as checkpoint inhibitors, cell-based therapies (including CAR T cells and tumor-infiltrating lymphocytes), and monoclonal antibodies. It also covers small-molecule targeted therapies, including kinase inhibitors (e.g., BRAF, MEK, EGFR) and agents such as PARP inhibitors and apoptosis promoters like BCL-2 inhibitors.\"},{\"question\":\"What are the main limitations of current evidence on reproductive safety?\",\"answer\":\"Available evidence is limited, heterogeneous, and often lacks baseline fertility assessment or long-term follow-up. This uncertainty complicates counselling, supporting a precautionary approach to fertility preservation.\"}]","Impact of immunotherapy and small molecule cancer therapy on fertility - a narrative review of current evidence, mechanisms and future directions | PDF",1790098852,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bcb85906d4b88b408b74457be6ffd18.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfc5d3bf3105166655e69e76ceb54bdc.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/089ed1a7683a2d100ab874ca9c2feacb.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd8d8c7f7c890b6dc9af8591a86ba7bf.webp",980,1306]